Log In
Print
BCIQ
Print
Print this Print this
 

sodium oxybate (Xyrem) (JZP-6)

Also known as: KEY-10

  Manage Alerts
Collapse Summary General Information
Company Jazz Pharmaceuticals plc
DescriptionOral liquid formulation of the sodium salt of gamma hydroxybutyrate (GHB)
Molecular Target GABA B receptor
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationExcessive sleepiness
Indication DetailsTreat cataplexy associated with narcolepsy; Treat excessive daytime sleepiness (EDS) associated with narcolepsy; Treat excessive daytime sleepiness (EDS) in combination with different stimulant medications; Treat excessive daytime sleepiness (EDS), fragmented nighttime sleep and cataplexy; Treat narcolepsy; Treat narcolepsy and reduce cataplexy; Treat narcolepsy with cataplexy in adult patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today